Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page
- Check2 days agoChange DetectedThe location entries for Zaporizhzhia in Ukraine have been updated to Zaporizhzhya with postal codes 69035 and 69600, adding two entries and removing the previous Zaporizhzhia spellings for those codes to reflect a standardized city name.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page shows a revision tag update from v3.6.3 to v3.6.4, indicating a small software update to the site hosting the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision tag v3.6.3 appears, replacing the previous v3.6.2, signaling a minor version update to the page's software. This update does not modify the study content or visible details.SummaryDifference0.0%

- Check38 days agoChange DetectedA newer revision (v3.6.2) has been added, replacing the previous revision (v3.6.0) in the study documents section.SummaryDifference0.0%

- Check52 days agoChange DetectedNew navigation and help sections were added, including How to Read a Study Record, Common Questions, How to Join a Study, and an updated Intervention/Treatment heading. The recruitment status was changed to No longer looking for participants, indicating enrollment has ended.SummaryDifference0.3%

- Check59 days agoChange DetectedThe page now displays Revision: v3.5.5 in place of Revision: v3.5.4, indicating a recent minor update to the page's revision metadata. This update does not alter visible content or functionality.SummaryDifference0.0%

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.